Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the FDA to resolve issues. read more ​  ​Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including reports of deaths and hospitalizations, while working with the

read more ​  ​read more 

read more ​  ​read more 

Aurora’s international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. read more ​  ​Aurora’s international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. read more 

Under Armour reported better-than-expected Q2 2025 results, with revenue declining 10.7% and adjusted EPS of $0.30. The company raised its full-year outlook, leading to a jump in its stock price. read more ​  ​Under Armour reported better-than-expected Q2 2025 results, with revenue declining 10.7% and adjusted EPS of $0.30. The company raised its full-year outlook,

Steven Madden, Ltd. (NASDAQ: SHOO) reported higher Q3 revenues, direct-to-consumer sales, and approved a dividend. FY24 guidance raised. read more ​  ​Steven Madden, Ltd. (NASDAQ: SHOO) reported higher Q3 revenues, direct-to-consumer sales, and approved a dividend. FY24 guidance raised. read more 

EPAM Systems reported Q3 sales of $1.17 billion, beating analyst estimate of $1.15B. Adjusted EPS of $3.12 also beat consensus of $2.70. read more ​  ​EPAM Systems reported Q3 sales of $1.17 billion, beating analyst estimate of $1.15B. Adjusted EPS of $3.12 also beat consensus of $2.70. read more 

Prominent chipmakers, including Taiwan Semiconductor Manufacturing Co (NYSE:TSM) and GlobalFoundries Inc (NASDAQ:GFS), have finalized agreements for substantial U.S. read more ​  ​Prominent chipmakers, including Taiwan Semiconductor Manufacturing Co (NYSE:TSM) and GlobalFoundries Inc (NASDAQ:GFS), have finalized agreements for substantial U.S. read more 

read more ​  ​read more 

read more ​  ​read more